Fortress Biotech
FBIO
#9477
Rank
โ‚น11.27 B
Marketcap
โ‚น339.45
Share price
-0.99%
Change (1 day)
99.44%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): โ‚น12.53 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are โ‚น66.16 Million. In 2025 the company made an earning of -โ‚น3.26 Billion, an increase over its 2024 earnings that were of -โ‚น11.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น12.53 B-485.01%
2025 -โ‚น3.26 Billion-72.02%
2024 -โ‚น11.64 Billion-21.6%
2023 -โ‚น14.84 Billion-28.03%
2022 -โ‚น20.62 Billion29.88%
2021 -โ‚น15.88 Billion59.8%
2020 -โ‚น9.94 Billion1.17%
2019 -โ‚น9.82 Billion-19.84%
2018 -โ‚น12.25 Billion28.99%
2017 -โ‚น9.5 Billion37.92%
2016 -โ‚น6.89 Billion32.31%
2015 -โ‚น5.21 Billion164.31%
2014 -โ‚น1.97 Billion-45.14%
2013 -โ‚น3.59 Billion37.55%
2012 -โ‚น2.61 Billion-22.91%
2011 -โ‚น3.39 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
โ‚น8.76 B-31.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.37 Billion-188.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚น3.29 Billion-125.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-โ‚น3.28 Billion-125.43%๐Ÿ‡บ๐Ÿ‡ธ USA